---
document_datetime: 2025-12-25 09:05:50
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/absimky.html
document_name: absimky.html
version: success
processing_time: 0.1057176
conversion_datetime: 2025-12-27 17:31:16.453044
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Absimky

[RSS](/en/individual-human-medicine.xml/250695)

##### Withdrawn

This medicine's authorisation has been withdrawn

ustekinumab Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Absimky](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 15 December 2025, the European Commission withdrew the marketing authorisation for Absimky (ustekinumab) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Accord Healthcare S.L.U., which notified the European Commission of its decision not to market the product in the EU for commercial reasons.

Absimky was granted marketing authorisation in the EU on 12 December 2024 for treatment of Crohn's disease, ulcerative colitis, plaque psoriasis, paediatric plaque psoriasis and psoriatic arthritis. The product had not been marketed in the EU.

Absimky was a duplicate application to Imuldosa, which is marketed in several EU countries. The marketing authorisation holder will maintain the marketing authorisation for Imuldosa.

Absimky : EPAR - Medicine overview

Reference Number: EMA/536423/2024

English (EN) (124.2 KB - PDF)

**First published:** 18/12/2024

**Last updated:** 18/12/2025

[View](/en/documents/overview/absimky-epar-medicine-overview_en.pdf)

[Other languages (22)](#file-language-dropdown-788)

български (BG) (152.66 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/bg/documents/overview/absimky-epar-medicine-overview_bg.pdf)

español (ES) (124.83 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/es/documents/overview/absimky-epar-medicine-overview_es.pdf)

čeština (CS) (145.33 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/cs/documents/overview/absimky-epar-medicine-overview_cs.pdf)

dansk (DA) (124.8 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/da/documents/overview/absimky-epar-medicine-overview_da.pdf)

Deutsch (DE) (125.33 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/de/documents/overview/absimky-epar-medicine-overview_de.pdf)

eesti keel (ET) (124.23 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/et/documents/overview/absimky-epar-medicine-overview_et.pdf)

ελληνικά (EL) (160.24 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/el/documents/overview/absimky-epar-medicine-overview_el.pdf)

français (FR) (125.23 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/fr/documents/overview/absimky-epar-medicine-overview_fr.pdf)

hrvatski (HR) (139.37 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/hr/documents/overview/absimky-epar-medicine-overview_hr.pdf)

italiano (IT) (124.71 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/it/documents/overview/absimky-epar-medicine-overview_it.pdf)

latviešu valoda (LV) (146.3 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/lv/documents/overview/absimky-epar-medicine-overview_lv.pdf)

lietuvių kalba (LT) (144.71 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/lt/documents/overview/absimky-epar-medicine-overview_lt.pdf)

magyar (HU) (138.87 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/hu/documents/overview/absimky-epar-medicine-overview_hu.pdf)

Malti (MT) (145.88 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/mt/documents/overview/absimky-epar-medicine-overview_mt.pdf)

Nederlands (NL) (124.92 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/nl/documents/overview/absimky-epar-medicine-overview_nl.pdf)

polski (PL) (144.93 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/pl/documents/overview/absimky-epar-medicine-overview_pl.pdf)

português (PT) (123.65 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/pt/documents/overview/absimky-epar-medicine-overview_pt.pdf)

română (RO) (143.13 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/ro/documents/overview/absimky-epar-medicine-overview_ro.pdf)

slovenčina (SK) (143.82 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/sk/documents/overview/absimky-epar-medicine-overview_sk.pdf)

slovenščina (SL) (139.13 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/sl/documents/overview/absimky-epar-medicine-overview_sl.pdf)

Suomi (FI) (124.71 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/fi/documents/overview/absimky-epar-medicine-overview_fi.pdf)

svenska (SV) (124.55 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/sv/documents/overview/absimky-epar-medicine-overview_sv.pdf)

Absimky : EPAR - Risk Management Plan

English (EN) (939.94 KB - PDF)

**First published:** 18/12/2024

**Last updated:** 18/12/2025

[View](/en/documents/rmp/absimky-epar-risk-management-plan_en.pdf)

## Product information

Absimky : EPAR - Product information

English (EN) (1.22 MB - PDF)

**First published:** 18/12/2024

**Last updated:** 18/12/2025

[View](/en/documents/product-information/absimky-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-491)

български (BG) (1.26 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/bg/documents/product-information/absimky-epar-product-information_bg.pdf)

español (ES) (1.19 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/es/documents/product-information/absimky-epar-product-information_es.pdf)

čeština (CS) (1.3 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/cs/documents/product-information/absimky-epar-product-information_cs.pdf)

dansk (DA) (1.09 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/da/documents/product-information/absimky-epar-product-information_da.pdf)

Deutsch (DE) (1.3 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/de/documents/product-information/absimky-epar-product-information_de.pdf)

eesti keel (ET) (1.1 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/et/documents/product-information/absimky-epar-product-information_et.pdf)

ελληνικά (EL) (1.44 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/el/documents/product-information/absimky-epar-product-information_el.pdf)

français (FR) (1.41 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/fr/documents/product-information/absimky-epar-product-information_fr.pdf)

hrvatski (HR) (1.22 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/hr/documents/product-information/absimky-epar-product-information_hr.pdf)

íslenska (IS) (1.2 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/is/documents/product-information/absimky-epar-product-information_is.pdf)

italiano (IT) (1.39 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/it/documents/product-information/absimky-epar-product-information_it.pdf)

latviešu valoda (LV) (1.19 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/lv/documents/product-information/absimky-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.27 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/lt/documents/product-information/absimky-epar-product-information_lt.pdf)

magyar (HU) (1.51 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/hu/documents/product-information/absimky-epar-product-information_hu.pdf)

Malti (MT) (1.3 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/mt/documents/product-information/absimky-epar-product-information_mt.pdf)

Nederlands (NL) (1.08 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/nl/documents/product-information/absimky-epar-product-information_nl.pdf)

norsk (NO) (1.13 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/no/documents/product-information/absimky-epar-product-information_no.pdf)

polski (PL) (1.39 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/pl/documents/product-information/absimky-epar-product-information_pl.pdf)

português (PT) (1.12 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/pt/documents/product-information/absimky-epar-product-information_pt.pdf)

română (RO) (1.28 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/ro/documents/product-information/absimky-epar-product-information_ro.pdf)

slovenčina (SK) (1.25 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/sk/documents/product-information/absimky-epar-product-information_sk.pdf)

slovenščina (SL) (1.23 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/sl/documents/product-information/absimky-epar-product-information_sl.pdf)

Suomi (FI) (1.19 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/fi/documents/product-information/absimky-epar-product-information_fi.pdf)

svenska (SV) (1.15 MB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/sv/documents/product-information/absimky-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** VR/0000272447 20/06/2025

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Absimky : EPAR - All authorised presentations

English (EN) (173.72 KB - PDF)

**First published:** 18/12/2024

**Last updated:** 18/12/2025

[View](/en/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-92)

български (BG) (182.36 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/bg/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_bg.pdf)

español (ES) (173.92 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/es/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_es.pdf)

čeština (CS) (176.63 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/cs/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (176.6 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/da/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (177.09 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/de/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (171.57 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/et/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (178.9 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/el/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_el.pdf)

français (FR) (173.73 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/fr/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (173.42 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/hr/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (176.07 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/is/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_is.pdf)

italiano (IT) (172.93 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/it/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (175.74 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/lv/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (174.73 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/lt/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (174.59 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/hu/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (176.47 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/mt/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (172.5 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/nl/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (175.3 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/no/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_no.pdf)

polski (PL) (175.95 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/pl/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_pl.pdf)

português (PT) (175.32 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/pt/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_pt.pdf)

română (RO) (173.4 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/ro/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (176.55 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/sk/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (102.71 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/sl/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (171.4 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/fi/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (173.5 KB - PDF)

**First published:**

18/12/2024

**Last updated:**

18/12/2025

[View](/sv/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Absimky Active substance ustekinumab International non-proprietary name (INN) or common name ustekinumab Therapeutic area (MeSH)

- Crohn Disease
- Colitis, Ulcerative

Anatomical therapeutic chemical (ATC) code L04AC05

### Pharmacotherapeutic group

Immunosuppressants

### Therapeutic indication

Plaque psoriasis

ABSIMKY is indicated for the treatment of moderate to severe plaque psoriasis in adults who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapies including ciclosporin, methotrexate (MTX) or PUVA (psoralen and ultraviolet A).

Paediatric plaque psoriasis

ABSIMKY is indicated for the treatment of moderate to severe plaque psoriasis in children and adolescent patients from the age of 6 years and older, who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.

Psoriatic arthritis (PsA)

ABSIMKY, alone or in combination with MTX, is indicated for the treatment of active psoriatic arthritis in adult patients when the response to previous non-biological disease-modifying antirheumatic drug (DMARD) therapy has been inadequate.

Crohn's Disease

Absimky is indicated for the treatment of adult patients with moderately to severely active Crohn's disease who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a TNFα antagonist or have medical contraindications to such therapies.

Ulcerative colitis

Absimky is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies.

## Authorisation details

EMA product number EMEA/H/C/006585

Biosimilar

This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the 'reference medicine'. For more information, see [Biosimilar medicines](/node/68323) .

Marketing authorisation holder

Accord Healthcare S.L.U.

Edificio Este Planta 6a

Opinion adopted 17/10/2024 Marketing authorisation issued 12/12/2024 Withdrawal of marketing authorisation 15/12/2025 Revision 4

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Absimky : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (730.98 KB - PDF)

**First published:** 28/05/2025

**Last updated:** 18/12/2025

[View](/en/documents/procedural-steps-after/absimky-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Absimky : EPAR - Public assessment report

Adopted

Reference Number: EMA/511029/2024

English (EN) (2.58 MB - PDF)

**First published:** 18/12/2024

**Last updated:** 18/12/2025

[View](/en/documents/assessment-report/absimky-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Absimky

Adopted

Reference Number: EMA/CHMP/448121/2024

English (EN) (122.29 KB - PDF)

**First published:** 18/10/2024

**Last updated:** 18/12/2025

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-absimky_en.pdf)

#### News on Absimky

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 October 2024](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-14-17-october-2024) 18/10/2024

**This page was last updated on** 18/12/2025

## Share this page

[Back to top](#main-content)